STRS Ohio’s Kestra Medical Technologies KMTS Stock Holding History

STRS Ohio’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,400	Closed	-$39.8K	–	2310
2025 Q2	$39.8K	Buy	+2,400	New	+$52.4K	﹤0.01%	2059

Other funds holding KMTS

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

STRS Ohio's KMTS Position: Q3 2025 in Review

STRS Ohio sold out of Kestra Medical Technologies (KMTS) in Q3 2025, closing a stake of 2,400 shares — an estimated $39.8K sold.

STRS Ohio first reported a position in KMTS in Q2 2025 and held it in 1 quarter. The position peaked at $39.8K in Q2 2025. 80 funds tracked by Wall St. Rank hold KMTS as of Q3 2025.

STRS Ohio reported no remaining Kestra Medical Technologies position as of Q3 2025 after selling out during the quarter.
STRS Ohio sold 2,400 Kestra Medical Technologies shares in Q3 2025, an estimated $39.8K.
STRS Ohio first reported a position in Kestra Medical Technologies in Q2 2025 and held it in 1 quarter.
STRS Ohio's Kestra Medical Technologies position peaked at $39.8K in Q2 2025.
80 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q3 2025.

Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.